CCM
MXCT icon

Cadian Capital Management’s MaxCyte MXCT Stock Holding History

Cadian Capital Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71M Buy
2,201,166
+478,224
+28% +$477K 0.2% 28
2026
Q1 		$1.21M Sell
1,722,942
-1,960,110
-53% -$1.83M 0.15% 23
2025
Q4 		$5.71M Sell
3,683,052
-4,544,551
-55% -$7.26M 0.41% 23
2025
Q3 		$13M Sell
8,227,603
-686,873
-8% -$1.19M 0.77% 22
2025
Q2 		$19.4M Sell
8,914,476
-1,113,251
-11% -$2.7M 1.09% 21
2025
Q1 		$27.4M Buy
10,027,727
+683,303
+7% +$2.69M 1.17% 25
2024
Q4 		$38.9M Buy
9,344,424
+1,155,476
+14% +$4.37M 2.24% 15
2024
Q3 		$31.9M Buy
8,188,948
+566,007
+7% +$2.38M 1.63% 21
2024
Q2 		$29.9M Buy
7,622,941
+1,062,457
+16% +$4.57M 1.49% 22
2024
Q1 		$27.5M Buy
6,560,484
+915,586
+16% +$4.3M 0.98% 25
2023
Q4 		$26.5M Buy
+5,644,898
New +$22M 1.06% 21

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cadian Capital Management's MXCT Position: Q2 2026 in Review

Cadian Capital Management increased its MaxCyte (MXCT) stake by 28% in Q2 2026, buying an estimated $477K and bringing the position to 2,201,166 shares worth $2.71M. The position accounts for 0.2% of the portfolio, ranked #28.

Cadian Capital Management first reported a position in MXCT in Q4 2023 and has held it in 11 quarters since. The position peaked at $38.9M in Q4 2024. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Cadian Capital Management held 2,201,166 shares of MaxCyte worth $2.71M as of Q2 2026.
  • Cadian Capital Management bought 478,224 MaxCyte shares in Q2 2026, an estimated $477K.
  • MaxCyte made up 0.2% of Cadian Capital Management's portfolio in Q2 2026, its #28 holding.
  • Cadian Capital Management first reported a position in MaxCyte in Q4 2023 and has held it in 11 quarters since.
  • Cadian Capital Management's MaxCyte position peaked at $38.9M in Q4 2024.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Cadian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.